Metatarsus Adductus, or Metatarsus Varus, stems from misalignment at the midfoot’s tarsometatarsal joints. While the condition occurs in nearly one out of every fourteen infants, the prevalence climbs to 12% among siblings of affected children. If left untreated, the deformity leads to chronic pain, gait instability, and potential hip dysplasia. For decades, clinicians relied exclusively on serial casting, a process that imposes significant physical and emotional strain on both infants and their families.
UNFO and OrthoPediatrics Launch Non-Invasive Foot Brace in U.S.
Affecting roughly 7% of all newborns, Metatarsus Adductus has long required painful casting or surgery to correct inward-turning feet. A new partnership between UNFO Med Ltd. and OrthoPediatrics now brings a non-invasive, FDA-approved corrective brace to the U.S. market, aiming to replace traditional, distressing treatment protocols.

Developed by pediatric orthopedic specialist Dr. Izak Daizade, the UNFO system offers a discreet, sandal-like alternative that sits below the ankle. The device corrects three-dimensional structural deformities through a non-surgical approach refined over thirty years of practice and a decade of specific research. Dr. Daizade reports a 95% success rate across his 15,000 treated patients. By integrating this technology into the OrthoPediatrics distribution network, the companies intend to shift standard pediatric care toward a more comfortable, proactive model that avoids the trauma of repeated casting.



Comments (0)
No comments yet. Be the first!